Research ArticlePsoriatic Arthritis
Open Access

Potential Impact of Sex and BMI on Response to Therapy in Psoriatic Arthritis: Post Hoc Analysis of Results From the SEAM-PsA Trial

Philip J. Mease, Dafna D. Gladman, Joseph F. Merola, Atul Deodhar, Alexis Ogdie, David H. Collier, Lyrica Liu and Arthur Kavanaugh
The Journal of Rheumatology August 2022, 49 (8) 885-893; DOI: https://doi.org/10.3899/jrheum.211037

References

  1. 1.↵
    1. Eder L,
    2. Haddad A,
    3. Rosen CF, et al
    . The incidence and risk factors for psoriatic arthritis in patients with psoriasis: a prospective cohort study. Arthritis Rheumatol 2016;68:915-23.
    OpenUrlPubMed
  2. 2.↵
    1. Menter A
    . Psoriasis and psoriatic arthritis overview. Am J Manag Care 2016;22:s216-24.
    OpenUrlPubMed
  3. 3.↵
    1. Ogdie A,
    2. Weiss P
    . The epidemiology of psoriatic arthritis. Rheum Dis Clin North Am 2015;41:545-68.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Singh JA,
    2. Strand V
    . Spondyloarthritis is associated with poor function and physical health-related quality of life. J Rheumatol 2009;36:1012-20.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Ritchlin CT,
    2. Colbert RA,
    3. Gladman DD
    . Psoriatic arthritis. N Engl J Med 2017;376:957-70.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Tillett W,
    2. Shaddick G,
    3. Askari A, et al
    . Factors influencing work disability in psoriatic arthritis: first results from a large UK multicentre study. Rheumatology 2015;54:157-62.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Boehncke WH,
    2. Menter A
    . Burden of disease: psoriasis and psoriatic arthritis. Am J Clin Dermatol 2013;14:377-88.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Kavanaugh A,
    2. Helliwell P,
    3. Ritchlin CT
    . Psoriatic arthritis and burden of disease: patient perspectives from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) survey. Rheumatol Ther 2016;3:91-102.
    OpenUrlPubMed
  9. 9.↵
    1. Ogdie A,
    2. Palmer JL,
    3. Greenberg J, et al
    . Predictors of achieving remission among patients with psoriatic arthritis initiating a tumor necrosis factor inhibitor. J Rheumatol 2019;46:475-82.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Højgaard P,
    2. Ballegaard C,
    3. Cordtz R, et al
    . Gender differences in biologic treatment outcomes–a study of 1750 patients with psoriatic arthritis using Danish Health Care Registers. Rheumatology 2018;57:1651-60.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Eder L,
    2. Thavaneswaran A,
    3. Chandran V,
    4. Gladman DD
    . Gender difference in disease expression, radiographic damage and disability among patients with psoriatic arthritis. Ann Rheum Dis 2013;72:578-82.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Singh S,
    2. Facciorusso A,
    3. Singh AG, et al
    . Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: a systematic review and meta-analysis. PLoS One 2018;13:e0195123.
    OpenUrlPubMed
  13. 13.↵
    1. Højgaard P,
    2. Glintborg B,
    3. Kristensen LE,
    4. Gudbjornsson B,
    5. Love TJ,
    6. Dreyer L
    . The influence of obesity on response to tumour necrosis factor-α inhibitors in psoriatic arthritis: results from the DANBIO and ICEBIO registries. Rheumatology 2016;55:2191-9.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Ogdie A,
    2. Coates LC,
    3. Gladman DD
    . Treatment guidelines in psoriatic arthritis. Rheumatology 2020;59 Suppl 1:i37-i46.
    OpenUrl
  15. 15.↵
    1. Gottlieb A,
    2. Merola JF
    . Psoriatic arthritis for dermatologists. J Dermatolog Treat 2020;31:662-79.
    OpenUrlPubMed
  16. 16.↵
    1. Gossec L,
    2. Baraliakos X,
    3. Kerschbaumer A, et al
    . EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. Ann Rheum Dis 2020;79:700-12.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Coates LC,
    2. Kavanaugh A,
    3. Mease PJ, et al
    . Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 treatment recommendations for psoriatic arthritis. Arthritis Rheumatol 2016;68:1060-71.
    OpenUrlPubMed
  18. 18.↵
    1. Singh JA,
    2. Guyatt G,
    3. Ogdie A, et al
    . Special article: 2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis. Arthritis Care Res 2019; 71:2-29.
    OpenUrlPubMed
  19. 19.↵
    1. Mease PJ,
    2. Gladman DD,
    3. Collier DH, et al
    . Etanercept and methotrexate as monotherapy or in combination for psoriatic arthritis: primary results from a randomized, controlled phase III trial. Arthritis Rheumatol 2019;71:1112-24.
    OpenUrlPubMed
  20. 20.↵
    1. Mease PJ,
    2. Gladman DD,
    3. Samad AS, et al
    . Design and rationale of the study of etanercept and methotrexate in combination or as monotherapy in subjects with psoriatic arthritis (SEAM-PsA). RMD Open 2018;4:e000606.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Taylor W,
    2. Gladman D,
    3. Helliwell P,
    4. Marchesoni A,
    5. Mease P,
    6. Mielants H; CASPAR Study Group
    . Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665-73.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Wright G,
    2. Nash P,
    3. Coates L, et al
    . Comparison of secukinumab versus adalimumab efficacy by sex in psoriatic arthritis from a phase 3b, double-blinded, randomized, active-controlled study [abstract]. Arthritis Rheumatol 2020;72 Suppl 10:0507.
    OpenUrl
  23. 23.↵
    1. Mease PJ
    . Fibromyalgia, a missed comorbidity in spondyloarthritis: prevalence and impact on assessment and treatment. Curr Opin Rheumatol 2017;29:304-10.
    OpenUrlPubMed
  24. 24.↵
    1. Nie J,
    2. Li YY,
    3. Zheng SG,
    4. Tsun A,
    5. Li B
    . FOXP3+ Treg cells and gender bias in autoimmune diseases. Front Immunol 2015;6:493.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Cutolo M,
    2. Sulli A,
    3. Capellino S, et al
    . Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus 2004;13:635-8.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Singh RP,
    2. Bischoff DS
    . Sex hormones and gender influence the expression of markers of regulatory T cells in SLE patients. Front Immunol 2021;12:619268.
    OpenUrl
  27. 27.↵
    1. Eder L,
    2. Thavaneswaran A,
    3. Chandran V,
    4. Cook RJ,
    5. Gladman DD
    . Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis. Ann Rheum Dis 2015;74:813-7.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Eder L,
    2. Abji F,
    3. Rosen CF,
    4. Chandran V,
    5. Gladman DD
    . The association between obesity and clinical features of psoriatic arthritis: a case-control study. J Rheumatol 2017;44:437-43.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Queiro R,
    2. Lorenzo A,
    3. Tejón P,
    4. Coto P,
    5. Pardo E
    . Obesity in psoriatic arthritis: comparative prevalence and associated factors. Medicine 2019;98:e16400.
    OpenUrl
  30. 30.↵
    1. Soltani-Arabshahi R,
    2. Wong B,
    3. Feng BJ,
    4. Goldgar DE,
    5. Duffin KC,
    6. Krueger GG
    . Obesity in early adulthood as a risk factor for psoriatic arthritis. Arch Dermatol 2010;146:721-6.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Enck P,
    2. Klosterhalfen S,
    3. Weimer K,
    4. Horing B,
    5. Zipfel S
    . The placebo response in clinical trials: more questions than answers. Philos Trans R Soc Lond B Biol Sci 2011;366:1889-95.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Merola JF,
    2. Ogdie A
    . SEAM-PsA: seems like methotrexate works in psoriatic arthritis? Arthritis Rheumatol 2019;71:1027-9.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

 Request Permissions

Bookmark this article

Jump to section

Keywords

BODY MASS INDEX
ETANERCEPT
METHOTREXATE
PSORIATIC ARTHRITIS
SEX

Keywords